Society Committees

AWARDS COMMITTEE

• Sidney H. Ingbar Lectureship Award
• Val Galton Lectureship Award
• Van Meter Lectureship Award
• Distinguished Service Award
• John B. Stanbury Thyroid Pathophysiology Medal Award
• Lewis Braverman Distinguished Lectureship Award

The Awards Committee shall select the recipients of the Van Meter Award, the Sidney H. Ingbar Distinguished Lectureship, the Val Galton Lectureship Award, the Lewis Braverman Distinguished Lectureship, the Distinguished Service Award and the John B. Stanbury Thyroid Pathophysiology Medal. Nominations forms are found on the ATA website www.thyroid.org, in the Annual Meeting Program book, and from the ATA office upon request.

Members of the committee shall help to promote nominations and make awards nominations as well.   When the discussion of a particular candidate is held the nominator is not required to recuse him or herself. If nominated, the Award Committee chairperson and members may not be considered as a nominee for an Award during his or her tenure on the committee. It is important that they be informed of this restriction at the time they are nominated for an Award and may choose to resign from the committee. Committee members will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Awards Committee Roster

Sheue-yann Cheng, Chair (2018-2020)
Peter Arvan (2017-2020)
Bernadette Biondi (2018-2021)
Quan-yang Duh (2019-2022)
Stephanie Fish (2017-2020)
Andrew Gianoukakis (2017-2020)
Whitney Goldner (2018-2021)
Yuri Nikiforov (2017-2020)
Geoffrey Young (2019-2022)
Board Liaison: Naifa Busaidy
Staff Liaison: Josette Paige

Bylaws Committee Charge

• Bylaws review
• Bylaws revision oversight

The Bylaws Committee will consist of up to four members.

The Bylaws Committee shall examine the Bylaws and Recommend appropriate changes to the Board and membership. The Bylaws committee shall keep a record of all bylaws changes recommended by the membership at annual meeting in order to incorporate them into written proposed amendments. The proposed amendments must be presented in writing to the membership 60 days before the annual business meeting. A two-thirds vote or more of members’ present will be required for passage.

Bylaws Committee Roster

CLINICAL AFFAIRS COMMITTEE

• Clinician public affairs
• Website presence for clinical information

The Clinical Affairs Committee shall review issues relevant to standards of practice in thyroid disease and update publications and other recommendations relating to practice guideline, which have been published on behalf of the Association regarding practice guidelines. The Committee shall also receive, review, and prepare responses to matters affecting the practice of clinical thyroidology, in coordination with the Public Health Committee as necessary. Clinical Affairs Committee members may be asked to represent the Association on practice, regulatory, and reimbursement issues. Committee members will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Clinical Affairs Committee Roster

Carol Greenlee, Co-Chair (2016-2020)
Valerie Peck, Co-Chair (2018-2020)
Sarimar Agosto Salgado (2019-2022)
Nathan Eric Carnell (2017-2020)
Leonidas Duntas (2017-2020)
Mayumi Endo (2019-2022)
Cheryl Fassler (2018-2021)
Henry Fein (2018-2021)
Jeffrey Garber (2018-2021)
Stephanie Lee (2018-2021)
Isabel Marcano (2019-2020)
Pieter Noordzij (2018-2021)
Gary Pepper (2017-2020)
Jennifer Perkins (2018-2021)
David Rosenthal (2015-2021)
Wendy Sacks (2018-2021)
Randall Scheri (2018-2021)
Colleen Veloski (2017-2020)
Board Liaison: Martha Zeiger
Staff Liaison: Carrie Prewitt

DEVELOPMENT COMMITTEE

• Establishes Corporate Leadership Council and Philanthropic Advisory Council
• Researches, vets and engages in exploring funding opportunities and revenue sources from stakeholders in the thyroid space to recommend, with plan and budget, to the  Board of Directors

The Development Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations, decisions and all interactions with internal and external stakeholders.

Development Committee Roster

Frances Carr, Co-Chair (2018-2020)
Michael McDermott, Co-Chair (2017-2020)
Paul Casanova-Romero (2019-2022)
Gary Clayman (2017-2020)
Hossein Gharib (2018-2021)
David Hughes (2019-2022)
Jina Kim (2019-2020)
Lawrence Kim (2018-2021)
Jennifer Lawrence (2017-2020)
Nicole Lebo (2019-2020)
John Lew (2019-2022)
Gregory Randolph (2018-2021)
Prasanna Santhanam (2017-2020)
Rokshana Thanadar (2017-2020)
Board Liaison: Ralph Tufano
Staff Liaisons: Kelly Hoff, Adonia Calhoun Coates

Ethics Advisory Committee Charge

The ATA Ethics Advisory Committee (EAC) advises the ATA Board in three main areas:

• Professional ethics issues
• Research ethics issues
• Clinical ethics issues

The EAC fulfills the above through four main activities:

1. Consultation. A request for an ethics opinion may come to the EAC through ATA members or the Board of Directors (BOD).
2.  Advisory communications. The EAC shall bring urgent and non-urgent agenda items to the ATA President or Secretary/COO or Executive Director’s attention (via phone call) before action is taken.
3.  Education. The EAC may suggest topics of educational interest for presentation at the annual meeting, as requested by the Program Committee.
4. Publications. The EAC shall periodically write articles and statements to be submitted for publication; after review and approval by the ATA Guidelines and Statement Committee and the ATA Board of Directors if necessary.

The ATA Ethics Advisory Committee shall consist of 7-9 members, including the chair. All members shall have a strong knowledge base or interest in bioethics.

Ethics Advisory Committee Roster

FINANCE AND AUDIT COMMITTEE

• Financial and Investment oversight
• Endowment
• Annual Fund
• Named funds

The Finance and Audit Committee is responsible for guidance and communication to the ATA Board of Directors relating to the finances of the ATA. The Finance and Audit Committee is comprised of the Chair, the Treasurer, the Treasurer-Elect (when appropriate) and active members. The Finance and Audit Committee reports to the ATA Board of Directors.

1. The Finance and Audit Committee shall review internal financial reports of the ATA on a quarterly basis. Recommendations from the Committee related to the reporting and or fiscal policies of the ATA shall be made to the ATA Board of Directors.
2. The Finance and Audit Committee shall maintain a continuing overview of the financial affairs of the Association and shall make recommendations concerning the fiscal management of the Association to the Board of Directors. Such overview shall include the annual budget proposed by the Executive Director, annual selection of the outside independent audit firm as proposed by the Executive Director, the final audit report and the IRS Form 990.
3. The Investment Policy Committee of the ATA Board of Directors will inform the Finance and Audit Committee on the spending policy in the Investment Policy Statement for the ATA Endowment Funds, as well as report on the Investment activities and performance on an annual basis.
4. The Finance and Audit Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Finance and Audit Committee Roster

Erik Alexander, Chair (2017-2020)
Giuseppe Barbesino (2019-2022)
Antonio Bianco (2017-2020)
Lindsay Bischoff (2019-2020)
Amy Chen (2017-2020)
Emad Kandil (2019-2022)
Marina Nikiforova (2018-2021)
Russell Smith (2018-2021)
Brendan Stack (2019-2022)
Maria Trovato (2018-2021)
Kristin Vella (2017-2020)
Julie Ann Sosa, Treasurer and Board Liaison
Staff Liaison: Josette Paige
Sheri Wilson, CPA, BBG

GUIDELINES AND STATEMENTS COMMITTEE

• Improve and sustain the quality of ATA Clinical Practice Guidelines (CPGs) and Statements
• Promote the dissemination of ATA documents and implementation of ATA CPGs
• Promote diversity among authors of ATA documents and patient stakeholder representation

The American Thyroid Association Board of Director’s has tasked the ATA Guidelines and Statements Committee (GSC) with the broad aim of improving and sustaining the quality of ATA Clinical Practice Guidelines (CPGs) and Statements, as well as promoting the dissemination of ATA documents and implementation of ATA CPGs. The GSC will promote diversity among authors of ATA documents as well as patient stakeholder representation.

The GSC will maintain an active list of official ATA guidelines and statements and evaluate proposals for new ATA guidelines and statements.  Furthermore, the GSC will track the yearly progress of ATA official, in-progress documents, and will assist in evaluation of initial drafts of the final documents, prior to review by the Board of Directors.

The competing interests of authors of ATA documents under development will be reviewed at inception of a new task force and then monitored, in conjunction with the CPG or Statement Chairs, and the BOD.  Any unmanageable conflicts will be communicated to CPG chairs and the Board of Directors. An opinion from ATA ethic representatives may be sought in certain cases when felt appropriate and requested by the Board of Directors. The ATA Board of Directors will be responsible for making a final recommendation on how to handle unmanageable conflicts when they arise.

The GSC will also provide recommendations and guidance about standardization of the methods for the development of ATA CPGs and other documents to the chairs of CPGs, particularly at the proposal and initial manuscript draft submission stage. The GSC, in collaboration with the Executive Committee, and other committee chairs, will regularly review will provide input to the Board of Directors on when an update or revision of a guideline or statement, or a new ATA work product, is needed. The GSC will also promote dissemination of ATA documents and implementation of ATA CPGs, working in collaboration with guideline chairs and the Board of Directors. The GSC will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Guidelines and Statements Committee Roster

Cord Sturgeon, Co-Chair (2018-2020)
Brian Kim, Co-Chair (2019-2020)
Peter Angelos (2017-2020)
Alessandro Antonelli (2019-2022)
Sofie Bliddal (2019-2020)
Juan P. Brito (2017-2020)
Dempi Desai (2019-2020)
Catherine Dinauer (2019-2022)
Bryan Haugen (2017-2020)
Electron Kebebew (2019-2022)
Peter Kopp (2017-2020)
Susan Mandel (2017-2020)
Benjamin Roman (2019-2022)
Douglas Ross (2017-2020)
David Sarne (2017-2020)
Catherine Sinclair (2017-2020)
Board liaison: Megan Haymart
Staff liaison: Kelly Hoff

HISTORY AND ARCHIVES COMMITTEE

• Archives of the ATA
• History of Thyroidology and related science
• Website development and oversight of “The Clark T. Sawin History Resource Center”
• Recommends the presenter and topic of the Sawin vignette at the Annual Meeting

The History and Archives Committee shall obtain, collate, file, and record relevant information pertaining to past, present, or future events of the Association. Photographs, audiovisual materials, and copies, or original data, of programs, abstracts, distinguished lectures, or the like, should be maintained at the Association’s Headquarters’ office.  Each spring the Committee discusses, determines and recommends the presenter and topic of the Sawin vignette for the Annual Meeting. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

History and Archives Committee Roster

Peter Kopp, Chair (2019-2020)
Kenneth Ain (2018-2021)
Christine Cherella (2019-2020)
Charles Emerson (2019-2023)
Thomas Fahey (2018-2021)
Valerie Anne Galton (2018-2021)
Jerome Hershman (2019-2023)
Stephen LaFranchi (2018-2021)
Elizabeth McAninch (2018-2021)
Sandra McLachlan (2017-2020)
Edward Merker (2019-2023)
Dan Mihailescu (2018-2021)
Carla Moran (2018-2021)
John Morris (2018-2021)
Fadi Nabhan (2015-2021)
Bob Smallridge (2017-2023)
Board liaison: Elizabeth Pearce
Staff Liaison: Sharleene Cano

INTERNATIONAL COORDINATING COMMITTEE (ICC)

• Sister society presidents and secretaries who meet annually to discuss international thyroid issues
• Select Program Organizing Committee Representatives to the International Thyroid Congress

The International Coordinating Committee shall consist of the current President, the Secretary/COO and the Executive Director.  The International Coordinating Committee will work closely with each of the other Thyroid Associations to help propose meeting sites and times and to help coordinate all relevant scientific, economic, and geographical considerations relevant to International Meetings. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

International Coordinating Committee (ICC) Roster

Jacqueline Jonklaas (2019-2023)
Martha Zeiger (2019-2020)
Staff liaison: Adonia Calhoun Coates

INTERNET AND SOCIAL MEDIA COMMUNICATIONS COMMITTEE

The Internet and Social Media Communications Committee serves as the editorial board of the ATA website. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Website Editorial Board Role:

• Review website for accuracy and up-to-date content
• Suggest revisions and supplemental content for the website that supports the ATA mission, communications and thyroid awareness
• Evaluate web initiatives
• Review web analytics and usage statistics
• Recommend website updates to the Board of Directors

Communications and Social Media Role:

• Participate in social media interactions that support the ATA social media strategy
• Evaluate social media initiatives and collaboration opportunities
• Provide suggestions to staff for ATA social media content

INTERNET AND SOCIAL MEDIA COMMUNICATIONS COMMITTEE

Website Editorial Board

Avital Harari, Chair (2019-2020)
Edward Chin (2018-2021)
Sophie Dream (2019-2020)
Mathew Ettelson (2019-2020)
Benjamin Gigliotti (2019-2022)
Mimi Hu (2018-2021)
Jochen Lorch (2019-2022)
Christian Nasr (2019-2022)
Sarah Oltmann (2018-2021)
Nitin Pagedar (2019-2022)
Krishna Pinnamaneni (2017-2020)
Sarika Rao (2019-2022)
Samira Sadowski (2019-2022)
Rupendra Shrestha (2018-2021)
Board Liaison: Tom Giordano
Staff Liaisons: Carrie Prewitt, Kelly Hoff

LABORATORY SERVICES COMMITTEE

The role of the Laboratory Services Committee is to serve as a resource to the ATA and its membership on all aspects of clinical laboratory testing relevant to thyroid health and disease. All members shall have a strong knowledge base and interest in clinical laboratory testing. Their combined knowledge base should cover most aspects of clinical laboratory practice relevant to clinical thyroidology. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

• At least three (3) member(s) shall be laboratory professionals or individuals primarily involved in clinical laboratory testing.
• At least three (3) member(s) shall be (near) full time clinicians.
• At least three (3) member(s) shall be basic or translational scientists or individuals primarily involved in such activities.

Lab Services Committee Roster

TBD –  CHAIR NEEDED ASAP
Shema Ahmad (2018-2021)
Joel Ehrenkranz (2017-2020)
Sana Ghaznavi (2019-2022)
Sina Jasim (2018-2021)
George Kahaly (2018-2021)
Chienying Liu (2018-2021)
Debora Mainardi-Novo (2019-2022)
Lauren Nicole Parsons (2019-2022)
Virginia Sarapura (2017-2020)
Vivian Weiss (2018-2021)
Board Liaison: Naifa Busaidy
Staff Liaisons: Kelly Hoff, Claudia Crail-Munoz

MEMBERSHIP PANEL

• Membership promotion, domestic and international
• Membership recruitment and retention
• Membership needs, programs and services

It is the duty of the Membership Panel to receive and review all applications for membership in the Association. The major criterion for membership shall be evidence of scholarly interest in the thyroid gland. The Membership Panel will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions. The names of those applicants whose credentials fulfill the requirements for membership and are approved for membership shall be referred to the Board of Directors. The Membership Panel through the Secretary/Chief Operating Officer shall inform in writing those applicants who have been rejected or held over of the action of the panel and the reason for that decision.

Membership Panel Roster

Jennifer Mammen, Chair (2019-2020)
Myriem Boufraqech (2019-2022)
Elizabeth Cottrill (2017-2020)
Tyler Drake (2018-2021)
Cristiane Gomes-Lima (2019-2020)
Ellen Marqusee (2017-2020)
James Suliburk (2019-2022)
Vishnu Sundaresh (2018-2021)
Ann Marie Zavacki (2019-2022)
Board Liaison: Antonio Di Cristofano
Staff Liaison: Carrie Prewitt

NOMINATING COMMITTEE

• Call for Nominations
• Evaluate and propose candidates for office

1. The ATA Nominating Committee is charged with providing the membership with a slate of candidates to fulfill the Board of Directors commitment to diversity and representation. The ATA strongly endorses the concept that our organization should be led by a balanced and representative governing body that reflects the ATA’s membership in terms of gender, race/ ethnicity, professional specialty, practice setting, career stage and academic activities. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.
2. After ascertaining willingness to serve on the part of the potential nominees, the Nominating Committee shall nominate at least two members for the offices of President and Directors. The nominating committee shall notify the Secretary/COO of those members nominated at least 75 days prior to each annual meeting. The Secretary/COO shall then notify the membership of the proposed candidates for elective office. Within the next thirty days, nominations by petition for elective office may be submitted. Such petitions require the signatures of at least 5% of the active members. Ballots are to be sent to the membership thirty days in advance of the annual meeting.
3. If nominated, the Nominating Committee chairperson and members may not stand as a candidate for any office during his or her tenure on the Committee.  It is important that they be informed of this restriction at the time they are offered the opportunity to join the committee.

Nominating Committee Roster

Susan Sherman, Chair (2018-2020)
Laura Boucai (2017-2020)
Gerard Doherty (2018-2021)
John Morris (2018-2021)
Sara Pai (2019-2022)
Steven Sherman (2018-2021)
Maisie Shindo (2018-2021)
Peter Singer (2018-2021)
Michael Thomas (2019-2022)
Vasyl Vasko (2019-2022)
Kristin Vella (2017-2020)
Board Liaison: Victor Bernet
Staff Liaison: Sharleene Cano

PATIENT AFFAIRS AND EDUCATION

• Public forums and Alliance for Thyroid Patient Education
• Website resources for patients
• Friends of the ATA members and e-news
• Clinical Thyroidology for Patients

The Chair will be an ATA member with preference for that individual being a practicing clinician. The committee should have one or more patient representatives, either from one of ATA’s patient alliance groups or from the community. Clinicians and clinical researchers with an interest in patient education should comprise the majority of the committee members.

The overarching goal for the Patient Affairs and Education Committee is to continually identify and pursue opportunities in support of the ATA goal to be the patient-preferred resource for education and information pertaining to thyroid disease. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

These efforts will include but not be limited to:

1. Compose, edit and update the patient education brochures on the ATA website, with input from other committees and subject to Board approval.
2. Review and recommend updates to all content on the patient education site on the ATA website.
3. Active outreach and collaboration with other ATA committees and lay based patient education groups.
4. Collaborate with sister professional societies with regard to thyroid patient education.
5. Participate in the organization, development and presentation of education programs targeted to thyroid patients and the public.
6. Plan and coordinate the Patient Forum held at the Annual ATA Meeting, as well as other community impact events throughout the year.  Maintain adequate ATA member representation at patient affairs events.
7. Explore opportunities for fundraising to support patient education and thyroid research, in coordination with Development Committee.

Patient Affairs & Education Committee Roster

Trevor Angell, Chair (2017-2020)
Trisha Cubb (2019-2022)
Kimberly Dorris (2018-2021)
Allen Ho (2018-2021)
Ken Kazahaya (2017-2020)
Melissa Lechner (2019-2020)
Sandra Licht (2018-2021)
Michele Merten (2018-2021)
Liuska Pesce (2019-2022)
Siobhan Pittock (2017-2020)
Joseph Scharpf (2018-2021)
Vibhavasu Sharma (2015-2020)
Connie Trump (2019-2022)
Jonathan Wasserman (2017-2020)
Board Liaison: Elizabeth  Pearce
Staff Liaisons: Kelly Hoff, Carrie Prewitt

PROGRAM COMMITTEES

Program for Annual Meeting

• Program for Annual Meeting
• CME/MOC Symposia
• Sawin Historical Vignette
• Bauman Clinical Symposium
• Programs for Spring Meetings and Symposia

1. The Annual Program Committee shall consist of a balance of specialty areas with members serving staggered three-year terms. In general, the Co-chairs, will represent clinical and basic science and shall have been committee members for two years. The Program Committee shall select from abstracts submitted to it those topics, subjects, or papers that are to be presented at the scientific meeting of the Association and to arrange their order of presentation.
2. No abstract, a major portion of which has been published or read before any other national or international meeting in North America shall be considered for presentation on the scientific program of the Association unless by special permission of the Program Committee.
3. The committee may with the consent of the Board of Directors arrange for invited lectures or symposia as part of the scientific program.
4. The Program committee shall follow the organizational timeline in order that faculty are invited, the program developed, and arrangements made by the headquarters’ staff to distribute the program.  All accepted abstracts will be published unless withdrawn by the author.
5. Those who have submitted abstracts and titles for the program will be informed as quickly as possible of the action of the committee after its deliberations.
6. Satellite programming to the annual meeting may be added as appropriate based on need, gap or interest as designated by the Board of Directors with consultation to the Program Committee. Consultation with staff shall be required to ensure the availability of contract meeting facility space to add additional programming.
7. The Program Committee shall support headquarters staff with the appropriate scientific information and data required to pursue continuing medical education accreditation and educational grant support.
8. ATA Program Committees will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Program Committee Roster

Program Committee – Personalized Approach to Thyroid Disorders: ATA Satellite Symposium
March 27, 2020 at ENDO, San Francisco, CA

Laura Boucai, Co-Chair
Francesco Celi, Co-Chair
Ramona Dadu
Douglas Forrest **
Joanna Klubo-Gwiezdzinska
Peter Kopp
Maria Papaleontiou
Luca Persani
Wendy Sacks
Rebecca Sippel
Board Liaison: Martha Zeiger
Staff Liaisons: Adonia Calhoun Coates, Sharleene Cano

Program Committee –Controversies in Thyroidology: ATA Spring Meeting
May 28-30, 2020, New York, NY

Whitney Goldner, Co-Chair
Kepal Patel, Co-Chair
Gregory A. Brent
James Brierley
Louise Davies
Stephanie Fish
Loren Wissner Greene
George Kahaly
Angela Leung
Mary Samuels
Jonathan Wasserman
Board Liaison: Martha Zeiger
Staff Liaisons: Adonia Calhoun Coates, Josette Paige

Program Committees Charge

• Program for Annual Meeting
• CME Symposia
• Sawin Historical Vignette
• Bauman Clinical Symposium
• Programs for Spring Meetings and Symposia

1. The Annual Program Committee shall consist of a balance of specialty areas with members serving staggered three-year terms. In general, the Co-chairs, will represent clinical and basic science and shall have been committee members for two years. The Program Committee shall select from abstracts submitted to it those topics, subjects, or papers that are to be presented at the scientific meetings of the Association and to arrange their order of presentation.
2. No abstract, a major portion of which has been published or read before any other national or international meeting in North America shall be considered for presentation on the scientific program of the Association unless by special permission of the Program Committee.
3. The committee may with the consent of the Board of Directors arrange for invited lectures or symposia as part of the scientific program.
4. The Program committee shall follow the organizational timeline in order that faculty are invited, the program developed, and arrangements made by the headquarters’ staff to distribute the program. All accepted abstracts will be published unless withdrawn by the author.
5. Those who have submitted abstracts and titles for the program will be informed as quickly as possible of the action of the committee after its deliberations.

Program Committee – Spring symposium 2019 Roster

PUBLICATIONS COMMITTEE

Publications Committee will work with the Board of Directors to maintain the relationship between the Association, the Editors-in-Chief and the publisher. Committee members will read/review all journals, print and electronic, and suggest improvements or changes to content, design, and distribution. The Editors-in Chief shall be ex officio members of this committee and provide written reports twice a year in Q2 and Q4. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

The Committee will:

• Submit all action items to the Board of Directors for approval
• Maintain familiarity with the policies governing publications and publications related social media
• Provide oversight for the editorial policies of publications (listed below)
• Provide guidance and advice to the Editors
• Review the publications’ financials
• Serve as an interface between the Association and its Editors-in-Chief
• Respect the editorial independence of the editors
• Advise the Board on new directions for the journal program and publications
• Develop surveys regarding readership needs and publication goals
• Provide strategic direction for use of social media to promote the journals
• Review key publication metrics – submissions, web analytics, downloads, page views, distribution, impact factor
• Assign the Chair to serve as a liaison to the Board of Directors and the Publisher

Editor-in-Chief selection:

• Selection task force will follow the Secretary-elect process
• Publications Committee Chair serves as chair of the selection task force with selected volunteers appointed by the ATA President-elect including the Board liaison, the secretary/COO, and a representative from Mary Ann Liebert, Inc., publishers
• Questions for the interview (by phone, video call or in person) are available in the file
• The recommendation for a candidate for Editor-in-Chief is to be approved by Board

Publications Committee Roster

Sareh Parangi, Chair (2019-2020)
Brendan Stack, Past Chair (2019-2020)
Debbie Chen (2019-2020)
Ricardo Correa (2018-2021)
Omar El Kawgi (2019-2020)
Alan Farwell, CT for the Public EIC
Sebastiano Filetti (2018-2021)
Abbey Fingeret (2018-2021)
Barry Inabnet, VideoEndocrinology EIC
Electron Kebebew, Thyroid EIC-Elect
Peter Kopp, Thyroid EIC
Angela Leung, Clinical Thyroidology EIC
Samuel Refetoff (2018-2021)
Jonathon Russell (2019-2022)
David Sharlin (2018-2021)
Board Liaison: Jacqueline Jonklaas
Staff Liaison: Sharleene Cano

PUBLIC HEALTH COMMITTEE

• Public Health advocacy, initiatives and education

It is the duty of the Public Health committee to receive, review, and prepare responses to information relevant to public health issues and the thyroid. Committee members may be asked to represent the Association at public forums. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Public Health Committee

Dan Toft, Chair (2018-2020)
Michael Bouvet (2018-2021)
Kaniksha Desai (2017-2020)
Susana Ebner (2018-2021)
Garth Essig (2018-2021)
Ulla Feldt-Rasmussen (2015-2021)
Larry Fox (2018-2021)
Meghan Garstka (2018-2021)
Valeria Guimaraes (2018-2021)
Cari Kitahara (2019-2022)
Donald McLeod (2017-2020)
Joanne Rovet (2018-2021)
Marika Russell (2019-2022)
Alex Tessnow (2018-2021)
Ad hoc KI issues: Arthur Schneider
Board Liaison: Angela Leung
Staff Liaisons: Claudia Crail-Munoz, Josette Paige

PUBLIC RELATIONS COMMITTEE

• Media Policy
• Program Press Relations

The Public Relations Committee shall consist of the Past President, the President-elect and the Executive Director.  It is the duty of this committee to review and disburse press inquiries for appropriate referral. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Public Relations Committee Roster

Elizabeth Pearce, Past President, Co-Chair, Ex Officio
Victor Bernet, President-Elect, Co-Chair, Ex Officio
Staff Liaison: Adonia Calhoun Coates

RESEARCH COMMITTEE

• Grant review for funding of thyroid research
• Promotion of thyroid research awareness and funding by outside organizations

The Research Committee shall be concerned with the following areas:

1. Review and score thyroid research grant applications based on scientific merit and select the projects to be funded.
2. Review thyroid research grant program process and policies annually to ensure it is commensurate with the National Institutes of Health’s standard grant submission process and policies. Make recommendations to change as needed.
3. Evaluate progress of funded thyroid research projects to be reported to the ATA Board and grant funders.
4. Review and approve/decline surveys to be sent as needed.
5. Provide guidance and support as needed to the Signaling Pathways Project to assist in the curation and reusability of datasets that are highly-relevant to investigators in the area of thyroid receptor signaling.
6. Recommend changes to the grant review process or selection parameters to the Board of Directors as needed.
7. Propose grantees to present at the annual meeting.
8. Update publication citations from the research grants given by the ATA.
9. Exercise the highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

Research Committee Roster

Anthony N. Hollenberg, Co-Chair (2019-2020)
Carmelo Nucera, Co-Chair (2018-2020)
Ali S. Alzahrani (2019-2022)
Kristin Boelaert (2017-2020)
Cintia Citterio (2018-2021)
Chrysoula Dosiou (2017-2020)
Salah-Eddine Bouyoucef (2019-2022)
Kirk Jensen (2016-2022)
Salma Khan (2019-2022)
Joanna Klubo-Gwiezdzinska (2018-2021)
Naris Nilubol (2019-2022)
Jesse Pasternak (2019-2022)
Mabel Ryder (2018-2021)
David Steward (2019-2022)
Chris Umbricht (2014-2020)
Di Wu (2019-2020)
Board Liaison: Douglas Forrest
Staff Liaison: Josette Paige

SURGICAL AFFAIRS COMMITTEE

• Fosters multidisciplinary, collaborative interactions
• Plans educational activities
• Identifies research efforts
• Develops statements and guidelines

The Surgical Affairs Committee seeks to improve patient care by fostering multidisciplinary, collaborative interactions through actively participating in the development of clinical practice guidelines, the planning and implementation of educational activities, the identification and encouragement of joint research efforts, and working to increase surgical membership within the ATA. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

1. Co-chaired by a General Surgeon and an Otolaryngologist – Head and Neck Surgeon, each serving two years in a staggered rotation as appointed by the ATA President.
2. Each chair serves as past-chair for one year.
3. The committee will be balanced equally between head and neck surgeons and endocrine surgeons.  Endocrinologists will also be invited to serve.

Surgical Affairs Committee Roster

Rosemarie Metzger, Co-Chair (2018-2020)
Michael Singer, Co-Chair (2019-2021)
Kevin Brumund, Past Chair (2019-2020)
Linwah Yip, Chair-Elect (2019-2020)
William   Armstrong (2018-2021)
Louise Davies (2017-2020)
Vincent Gemma (2019-2020)
Elizabeth Grubbs (2018-2021)
Richard Robbins (2018-2021)
Jennifer Rosen (2019-2022)
David Shonka (2018-2021)
Philip Smith (2019-2022)
Marius Stan (2019-2022)
Tracy Wang (2018-2021)
Mark Zafereo (2018-2021)
Board Liaison: Joshua Klopper
Staff Liaison: Sharleene Cano

TRAINEES AND CAREER ADVANCEMENT COMMITTEE

• Primary responsibility for Trainees’ Programs and Initiatives
• Promotes visibility of benefits of ATA to Trainees

The Trainees and Career Advancement Committee shall promote professional development and career advancement opportunities for trainees and early career professionals who are interested in advancing their knowledge of thyroid physiology, disease and treatment. The Committee will exercise highest ethical standards, be transparent in dualities and conflicts of interest, and aim to be diverse, equitable and inclusive throughout their deliberations and decisions.

• Plans educational opportunities and initiatives for trainees and early career members.
• Encourages and supports trainee research and participation in ATA scientific programs.
• Fosters collegial relationships and interactions with thyroid experts and legacy members.
• Promotes visibility of benefits of ATA membership to trainees.

Trainees and Career Advancement Roster

Tracy Tylee, Co-Chair (2018-2020)
Aime Franco, Co-Chair (2019-2020)
Jacqueline Kung, Past Chair (2019-2020)
Sarah Ahmadi (2017-2020)
Noelle Gillis (2019-2020)
Poorani Goundan (2018-2021)
Aarti Mathur (2019-2022)
Lilah Morris-Wiseman (2017-2021)
Jennifer Morrison (2012-2020)
Susanne Neumann (2017-2020)
Yun-Bo Shi (2016-2020)
Jay Silverberg (2018-2021)
Johnson Thomas (2018-2021)
Marilene Wang (2017-2020)
Steve Weitzman (2015 – 2021)
Dorina Ylli (2019-2022)
Ai Yoshihara (2019-2022)
Board Liaison: Elizabeth Pearce
Staff Liaison: Sharleene Cano

GOALS of Women in Thyroidology (WIT):

Recruit and retain more women ATA members.

• More than 50% of graduating medical students and about 50% of endocrine fellows are women, 37% of ATA members are women (up from 10% in 2002).
• Actively recruit women endocrine fellows, members of other medical and scientific organizations, and authors of ATA abstracts and other publications about the thyroid.
• Welcome and mentor new women Associate Members to promote collegiality, network scientifically and socially, and encourage progressing to Active Membership.

Increase women’s visibility within ATA.

• Nominate more qualified women to committee and leadership positions.
• Encourage and promote the nomination of more women for ATA awards.
• Suggest the names of women to participate in the annual meeting scientific program.

Better address women’s thyroid health topics at ATA and other meetings.

• Increase coverage of autoimmune thyroid disease, maternal hypothyroidism, and thyroid disease and obesity.

Engage Women in Thyroidology in technology to promote professional and personal interaction.

Women in Thyroidology Roster

Megan Haymart, President (2019-2020)
Sissy Jhiang, Past President (2019-2020)
M. Regina Castro, President-Elect (2019-2020)
Debbie Chen (2019-2022)
Sophie Dream (2019-2022)
Aime Franco (2017-2020)
Masha Livhits (2017-2020)
Spyridoula Maraka (2017-2020)
Jennifer Perkins (2017-2021)
Lourdes Quintanilla-Dieck (2018-2021)
Rebecca Schweppe (2019-2022)

Anaplastic Thyroid Cancer Guidelines

Keith Bible, Co-Chair
Electron Kebebew, Co-Chair
Robert Smallridge, Past Chair
James Brierley
Juan Brito Campana
Maria Cabanillas
Thomas J. Clark, Jr.
Antonio Di Cristofano
Robert Foote
Thomas Giordano
Jan Kasperbbauer
Kate Newbold
Yuri Nikiforov
Gregory Randolph
Sara Rosenthal
Anna Sawka
Manisha Shah
Ashok Shaha
Carol K. Wong-Clark
Board Liaison: Victor Bernet
Staff Liaison: Sharleene Cano

Medullary Thyroid Cancer Registry

Multi-lateral Conference – Martinique

Treasurer-Elect Search

Susan Sherman, Chair
Victor J. Bernet
Jacqueline Jonklaas
Elizabeth Pearce
Richard Robbins
Julie Ann Sosa
Martha Zeiger
Sheri Wilson
Staff Liaison: Bobbi Smith

Executive Director Search

John Morris
Victor Bernet
Gregory Brent
Amy Chen
Charles Emerson
Jacqueline Jonklaas
Elizabeth Pearce
Rebecca Schweppe
Julie Ann Sosa
Martha Zeiger

Thyroid ^®

Editor-in-Chief: Peter A. Kopp
The leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases.

Thyroid^® Editorial Board

Editor-in-Chief
Electron Kebebew

Associate Editors

Sheue-yann Cheng
Leonidas H. Duntas
Megan Haymart
Laszlo Hegedüs
Elizabeth N. Pearce
Joachim Pohlenz
Douglas Ross

Editorial Board

Takashi Akamizu
Ali S. Alzahrani
Trevor E. Angell
Fereidoun Azizi
Jung Hwan Baek
Giuseppe Barbesino
Carlos Benbassat
Antonio C. Bianco
Martin Biermann
Bernadette Biondi
Gabriela Brenta
Luca Chiovato
Louise Davies
Terry F. Davies – EDITOR EMERITUS
Quan-Yang Duh
Cosimo Durante
Rossella Elisei
Charles H. Emerson – EDITOR EMERITUS
Laura Fozzatti
Melanie Goldfarb
Haixia Guan
Shirin Haddady
Jerome Hershman – EDITOR EMERITUS
Sissy M. Jhiang
Jacqueline Jonklaas
Won Bae Kim
Won Gu Kim
Edna T. Kimura
Shioko Kimura
Cari Kitahara
Irwin Klein
Josef Koehrle
Peter A. Kopp – EDITOR EMERITUS
Tim Korevaar
Sophie Leboulleux
Virginia A. LiVolsi
Cary N. Mariash
Sandra McLachlan
Donald McLeod
Marco Medici
Akira Miyauchi
Luc Morris
Yuji Nagayama
Carmelo Nucera
Tania Ortiga Carvalho
Ralf Paschke
Robin Peeters
Luca Persani
Gregory Randolph
Basil Rapoport
Salman Razvi
Scott Rivkees
Anna Sawka
Arthur B. Schneider
Bingyin Shi
Yun-Bo Shi
Christine Spitzweg
Cord Sturgeon
Gerasimos Sykiotis
Weiping Teng
Franklin Tessler
Yaron Tomer
Douglas Van Nostrand
Lori J. Wirth
Shunichi Yamashita
Michael W. Yeh

Editorial Office

Sharleene Cano, CAE

Clinical Thyroidology ^®

Editor-in-Chief: Angela M. Leung
Commentaries of the latest and impactful articles in the clinical thyroid literature are an important resource for those who care for patients with both benign and malignant thyroid disease.

Clinical Thyroidology^® Editorial Board

Editor-in-Chief
Angela M. Leung

Associate Editors

Trevor E. Angell
Martin Biermann
Bernadette Biondi
David S. Cooper
Catherine A. Dinauer
Tyler C. Drake
Charles H. Emerson
Benjamin J. Gigliotti
Haixia Guan
Shashank R. Joshi
Brian W. Kim
Tim I.M. Korevaar
Sun Y. Lee
Masha J. Livhits
Jochen H. Lorch
Akira Miyauchi
Lisa A. Orloff
Maria Papaleontiou
Elizabeth N. Pearce
Mary H. Samuels
Marius N. Stan
Daniel J. Toft,
Tracy S. Wang
Michael W. Yeh
Jerome Hershman – Editor Emeritus

VideoEndocrinology ™

Editor-in-Chief: William B. Inabnet III
Peer-reviewed videos of cutting-edge surgical and diagnostic imaging procedures covering thyroid, parathyroid, and adrenal tumors and diseases, with minimally invasive, robotic, and open surgical procedures.

VideoEndocrinology™ Editorial Board

Editor-in-Chief
William B. Inabnet III

Associate Editors      

Ralph P. Tufano
R. Michael Tuttle
Michael W. Yeh

Social Media Editor

James Wu

Editor Emeritus

Gerard M. Doherty, MD

Editorial Board  

Angkoon Anuwong
Eren Berber
Bruno Carnaille
Sally Carty
Shih-Ping Cheng
Giovanni Dapri
Quan-Yang Duh
Daniel Kelly
Stephanie Lee
Mira Milas
Barbra Miller
Sareh Parangi
Nancy Perrier
Gregory Randolph
Michael Singer
Brendan Stack
Cord Sturgeon
Hyunsek Suh
David Terris
Bo Wang

Clinical Thyroidology^® for the Public

Clinical Thyroidology^® for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association^®.

Clinical Thyroidology^® for the Public Editorial Board

Editor
Alan P. Farwell

Editorial Board

Jessie Block-Galaraza
Gary Bloom
Susana Ebner
Alina Gavrila
Melanie Goldfarb
Shirin Haddady
Sun Lee
Joshua Klopper
Priya Mahajan
Maria Papaleontiou
Jason D. Prescott
Marjorie Safran
Anna M. Sawka
Phillip Segal
Vibhavsu Sharma
Ebru Sulanc
Whitney Woodmansee